The Frederick National Laboratory for Cancer Research (FNL) has a new installation: a wall featuring 34 plaques highlighting patents granted to FNL researchers in recognition of their inventions and the breakthrough work being done at the laboratory. The “Innovations in Research” wall represents the mission of FNL staff to address some of the most urgent challenges in the biomedical sciences.

With 100 online attendees, 180 in-person participants, 15 posters, 16 technologies, and 45 speakers, the 2023 Technology Showcase offered a whirlwind look into biotechnology innovation happening at the Frederick National Laboratory for Cancer Research and National Cancer Institute.

The National Cancer Institute and Frederick National Laboratory for Cancer Research will host the Technology Showcase on Wednesday, September 6, at the FNL’s Advanced Technology Research Facility in Frederick, Md. The seventh annual event highlights NCI and FNL inventions and capabilities available to the external healthcare and biotech communities and offers the opportunity for networking with others in the biomedical research field.

A new drug and vaccine delivery method that utilizes synthetic bacterial nanoparticles could improve chemotherapy treatments, and a groundbreaking alternative to drilled wells may soon be breaking ground in agricultural areas. The Federal Laboratory Education Accelerator and the work of Master of Business Administration (MBA) students across the country are helping move these and other far-ranging technologies out of the laboratory and into the market.

Frederick National Laboratory’s Academic Summer Trainees Program provides graduate and undergraduate students with the chance to work with and learn from some of the nation’s leading scientists. The program now includes students from several Historically Black Colleges and Universities (HBCUs) and offers them increased access to advanced research and training, along with experience in biomedical programs, cancer research, and state-of-the-art technologies at FNL.